Oncolyze Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Crowdfunding
  • (Cancelled)

Oncolyze General Information

Description

Provider of biotherapeutics services intended to treat cancer. The company develops anti-cancer drugs that combine suitably well with chemotherapy and finds a cancer-specific protein that sits on the external surface of nearly all cancer cells but not normal cells and anchors, the active piece pokes holes in the surface, killing the cancer cell almost instantly, enabling cancer patients to get relief from painful treatments and increase their chances of surviving.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 845 Un Plaza, Apartment 61B
  • New York, NY 10017
  • United States
+1 (917)
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 845 Un Plaza, Apartment 61B
  • New York, NY 10017
  • United States
+1 (917)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncolyze Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Equity Crowdfunding 01-Jul-2022 Cancelled Clinical Trials - General
4. Later Stage VC (Series A) 06-Jul-2022 Completed Clinical Trials - General
3. Seed Round 30-Jun-2018 Completed Clinical Trials - General
2. Seed Round 07-Jan-2014 $1.1M $1.25M Completed Clinical Trials - General
1. Seed Round 31-Dec-2013 $155K $155K Completed Clinical Trials - General
To view Oncolyze’s complete valuation and funding history, request access »

Oncolyze Patents

Oncolyze Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230346708-A1 Stable formulations of anti-cancer peptides Pending 06-Jan-2020
EP-3773660-A4 Compositions for use in lysis of selective cancer cells Pending 08-Apr-2019
AU-2020225275-A1 Hdm2 antibody for use in treating cancer Pending 20-Feb-2019
EP-3927362-A4 Hdm2 antibody for use in treating cancer Pending 20-Feb-2019
EP-3927362-A1 Hdm2 antibody for use in treating cancer Pending 20-Feb-2019 C07K16/32
To view Oncolyze’s complete patent history, request access »

Oncolyze Executive Team (7)

Name Title Board Seat
Steven Evans MD Co-Founder, Chief Executive Officer and Board Member
Barbara Carlin Chief Financial Officer
Aleksandar Stojanovic MD Chief Operating Officer
Larry Altstiel Ph.D Chief Scientific Officer
John Abeles MD Co-Founder, Board Member & Chief Corporate Development and Strategy Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Oncolyze Board Members (5)

Name Representing Role Since
Alexander Zukiwski MD Self Clinical Advisor and Board Member
James Foght Ph.D Self Board Member and Business Advisor
John Abeles MD Oncolyze Co-Founder, Board Member & Chief Corporate Development and Strategy Officer
Rosemary Mazanet Ph.D Self Board Member and Clinical Advisor
Steven Evans MD Oncolyze Co-Founder, Chief Executive Officer and Board Member
To view Oncolyze’s complete board members history, request access »

Oncolyze Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oncolyze FAQs

  • When was Oncolyze founded?

    Oncolyze was founded in 2011.

  • Who is the founder of Oncolyze?

    Steven Evans MD and John Abeles MD are the founders of Oncolyze.

  • Who is the CEO of Oncolyze?

    Steven Evans MD is the CEO of Oncolyze.

  • Where is Oncolyze headquartered?

    Oncolyze is headquartered in New York, NY.

  • What is the size of Oncolyze?

    Oncolyze has 5 total employees.

  • What industry is Oncolyze in?

    Oncolyze’s primary industry is Therapeutic Devices.

  • Is Oncolyze a private or public company?

    Oncolyze is a Private company.

  • What is Oncolyze’s current revenue?

    The current revenue for Oncolyze is .

  • How much funding has Oncolyze raised over time?

    Oncolyze has raised $3.27M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »